R. Michael Carruthers Net Worth & Insider Trades

R. Michael Carruthers - Interim President / CFO, Nivalis Therapeutics, Inc

As of January 23, 2017

What is R. Michael Carruthers's Net Worth?

The current estimated net worth of Nivalis Therapeutics, Inc's Interim President / CFO, R. Michael Carruthers, is estimated to be about $130.54K . R. Michael Carruthers owns about 24,000 units of Nivalis Therapeutics, Inc common stock. In the last 2 years at Nivalis Therapeutics, Inc, R. Michael Carruthers has sold an estimated value of $0 worth.

What is R. Michael Carruthers's Past Insider Trading?

R. Michael Carruthers's largest purchase order was 24,000 units , worth over $50.26K on December 5, 2016. In total, R. Michael Carruthers has made about 4 transactions over 2 years of their time at Nivalis Therapeutics, Inc. R. Michael Carruthers usually trades in September, with the busiest year in 2016.

R. Michael Carruthers

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is R. Michael Carruthers's' Mailing Address?

  • Mailing address is 3122 Sterling Circle, Suite 200 Boulder CO 80301 CO

What are Nivalis Therapeutics, Inc's Past Insider Trades?

Nivalis Therapeutics, Inc's most recent insider trade came on June 22, 2017 by Pil Partners Bvf, Fund Value Biotechnology, Biotechnology Value Fund Ii Lp, Biotechnology Value Trading Fund Os Lp, Bvf Partners Os Ltd, Incil Bvf and Mark Lampert who bought 17,806 units worth $40.06K . In the last 2 years, insiders at Nivalis Therapeutics, Inc have sold an estimated value of $89.23K and bought an estimated value of $12.58M worth of shares. Insider trading is most common in September, with the busiest year in 2015. The most active traders at the company are Robert Conway, Director,  Jon Congleton, President and CEO,  and Biotechnology Value Fund Ii Lp .

Nivalis Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1